Jillian M. Carr
Frome Rd
Adelaide, SA 5000, Australia
Adelaide, SA 5000, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Application of an allele-specific PCR to clinical HIV genotyping samples detects additional K103N mutations in both therapy naïve and experienced patients.
Journal: Journal of medical virology
Published: October 27, 2009
Human immunodeficiency virus 1 (HIV-1) virion infectivity factor (Vif) is part of reverse transcription complexes and acts as an accessory factor for reverse transcription.
Journal: Virology
Published: August 16, 2007
Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical samples: levels are not associated with clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy.
Journal: Journal of clinical microbiology
Published: February 23, 2007
Cellular interactions of virion infectivity factor (Vif) as potential therapeutic targets: APOBEC3G and more?
Journal: Current drug targets
Published: December 16, 2006
Vif-deficient HIV reverse transcription complexes (RTCs) are subject to structural changes and mutation of RTC-associated reverse transcription products.
Journal: Virology
Published: January 10, 2006
Supernatants from dengue virus type-2 infected macrophages induce permeability changes in endothelial cell monolayers.
Journal: Journal of medical virology
Published: February 26, 2003
Effect of deletion and the site of insertion in double copy anti-tat retroviral vectors: viral titres and production of anti-tat mRNA.
Journal: Archives of virology
Published: January 05, 2002
Rapid and efficient cell-to-cell transmission of human immunodeficiency virus infection from monocyte-derived macrophages to peripheral blood lymphocytes.
Journal: Virology
Published: December 22, 1999
Showing 1-8 of 8
Last Updated: 09/26/2026